Champions Oncology (CSBR) Earnings Date, Estimates & Call Transcripts → The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique Way (From Smallcaps Daily) (Ad) Free CSBR Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipShort InterestSocial MediaSustainability Earnings SummaryUpcoming Earnings DateJul. 22EstimatedActual EPS (Mar. 12) -$0.19 Missed By -$0.19 Get Champions Oncology Earnings AlertsEnter your email address below to receive the latest news and earnings results for CSBR and its competitors with MarketBeat's FREE daily newsletter. Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueCSBR Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.CSBR Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad InvestorPlaceThe new financial threat that could wipe out millions…During the Internet boom, companies like Pets.com were supposed to be promising investments riding the wave of a new tech boom. But then they were gone within a blink of an eye. One of the most successful investors in history just stepped forward to say the same thing is about to happen to AI stocks.Pay close attention to this important video CSBR Earnings Date and InformationChampions Oncology last released its quarterly earnings data on March 12th, 2024. The biotechnology company reported ($0.19) EPS for the quarter. The firm earned $12.02 million during the quarter. Champions Oncology has generated ($0.72) earnings per share over the last year (($0.72) diluted earnings per share). Champions Oncology has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Monday, July 22nd, 2024 based off prior year's report dates.Read More Champions Oncology Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript 7/22/2024Estimated)------- 3/12/2024Q3 2024-($0.19)($0.19)($0.19)-$12.02 million12/12/2023Q4 2023($0.17)($0.15)+$0.02($0.15)$12.62 million$11.57 million 9/13/2023Q1 2024-($0.19)($0.19)($0.19)-$12.56 million7/24/2023Q4 2023-($0.19)($0.19)($0.19)$12.84 million$13.07 million3/15/2023Q3 2023($0.06)($0.18)($0.12)($0.18)$12.49 million$12.77 million9/8/2022Q1 2023$0.01($0.02)($0.03)($0.02)$13.44 million$13.75 million Get the Latest News and Ratings for CSBR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Champions Oncology and its competitors with MarketBeat's FREE daily newsletter. 7/21/2022Q4 2022$0.02($0.03)($0.05)($0.03)$12.84 million$12.88 million3/15/2022Q3 2022$0.03$0.05+$0.02$0.05$12.68 million$13.19 million 12/12/2021Q2$0.0050$0.02+$0.0150$0.02$11.43 million$11.79 million 9/12/2021Q1$0.01($0.01)($0.02)($0.01)$11.00 million$11.25 million 7/22/2021Q4$0.01($0.04)($0.05)($0.04)$10.20 million$10.57 million Champions Oncology Earnings - Frequently Asked Questions When is Champions Oncology's earnings date? Champions Oncology has not confirmed its next earnings publication date, but the company's estimated earnings date is Monday, July 22nd, 2024 based off last year's report dates. Learn more on CSBR's earnings history. How much revenue does Champions Oncology generate each year? Champions Oncology (NASDAQ:CSBR) has a recorded annual revenue of $53.87 million. How much profit does Champions Oncology generate each year? Champions Oncology (NASDAQ:CSBR) has a recorded net income of -$5.34 million. CSBR has generated -$0.72 earnings per share over the last four quarters. More Earnings Resources from MarketBeat Related Companies: Elutia Earnings Results Instil Bio Earnings Results Precision BioSciences Earnings Results Ikena Oncology Earnings Results Cognition Therapeutics Earnings Results Athira Pharma Earnings Results Turnstone Biologics Earnings Results LENZ Therapeutics Earnings Results Aligos Therapeutics Earnings Results Gritstone bio Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Traders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution GE Aerospace is Ready for Liftoff After Strong EarningsTaiwan Semiconductor Earnings: AI Dominance and Future Outlook This page (NASDAQ:CSBR) was last updated on 5/8/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaAI “wealth window” is closing June 25thParadigm PressThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsGold Set to EXPLODE!Gold Safe ExchangeCharles Payne Demystifies OptionsUnstoppable ProsperityShocking: One AI startup's revenue could surge 4,735%Manward Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Champions Oncology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.